The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Lithium: current state of the art and future directions
Open accessAbstract
BACKGROUND: Lithium is our oldest continuously prescribed medication in psychopharmacology, with its history as an agent for treating mood disorders extending from the 19th century. Although clinicians prescribe it less frequently than in the past, its utility in treating bipolar disorder is unquestionable. Novel potential indications for its use in psychiatry have created excitement about broader roles for lithium in treating and preventing other disorders. CONTENT: Lithium is effective both in treating acute mania, as an adjunctive antidepressant, and as a maintenance treatment in bipolar disorder. Lithium has also shown some efficacy in treating and preventing unipolar depression, but less clearly than for bipolar maintenance treatment and acute mania. Common side effects include nausea, polyuria, tremor, weight gain and cognitive dulling. These side effects are typically manageable with reasonable clinical strategies. Lithium affects renal, thyroid and parathyroid function. With clinical monitoring, these effects are easily managed although infrequent cases of severe renal insufficiency may occur with long term use. Although not all studies are positive, a consistent database suggests the efficacy of lithium in decreasing suicide attempts and suicides, likely due to its effect on impulsivity and aggression as well as its prophylaxis against depressive and manic recurrences. Recent data have suggested lithium's potential efficacy for a number of new clinical indications. Lithium's neuroprotective effects suggest potential efficacy in preventing mild cognitive impairment (MCI) and dementia as well as in aiding recovery from strokes. Higher (but still trace) lithium levels in drinking water are associated with lower rates of dementia. It is still not clear how much lithium-and what serum lithium levels- are required for either of these effects. Other preliminary research suggests that lithium may also have antiviral effects and may decrease cancer risk. CONCLUSIONS: Lithium continues to be the mainstay treatment of mood disorders in general and in bipolar disorder specifically. Other potential clinical uses for lithium in psychiatry have re-invigorated excitement for research in other areas such as suicide, preventing cognitive impairment and possibly preventing viral infections and diminishing cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“calibrated AMPAR facilitation may help sustain prefrontal drive, preserve signal-to-noise, and extend remission without excessive excitatory load [380,381,382].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [382]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Lithium treatment extends human lifespan: findings from the UK Biobank
Araldi, E., Jutzeler, C. R., & Ristow, M. (2023) · Aging · doi:10.18632/aging.204476 · Cited by 18
RetractedGlobal Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
Hill, N. R., Fatoba, S. T., Oke, J. L., Hirst, J. A., O’Callaghan, C. A., Lasserson, D. S., & Hobbs, F. D. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158765 · Cited by 4,030
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
LITHIUM SALTS IN THE TREATMENT OF PSYCHOTIC EXCITEMENT
Cade, J. F. J. (1949) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1949.tb36912.x · Cited by 1,463
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Lithium salts in the treatment of psychotic excitement
Cade, J. F. J. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.1999.06241.x · Cited by 1,150
Cohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920
Decreased risk of suicides and attempts during long‐term lithium treatment: a meta‐analytic review
Baldessarini, R. J., Tondo, L., Davis, P., Pompili, M., Goodwin, F. K., & Hennen, J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00344.x · Cited by 753
Lithium-induced increase in human brain grey matter
Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., & Menji, H. K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02793-8 · Cited by 649
Research works printed but not linked: 1
- Lange C. Om Periodiske Depressionstilstande og deres Patogenese [On Periodical Depressions and their Pathogenesis]. Copenhagen: Jacob Lunds Forlag, 1895 (2nd edition).
Cited by
de Paula, V. D. J. R., Radanovic, M., & Forlenza, O. V. (2025) · International Journal of Bipolar Disorders · doi:10.1186/s40345-025-00386-7 · Cited by 26
Bindel, L. J., & Seifert, R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04389-0 · Cited by 18
“…may be due to the explicit recommendation of lithium as a first-line treat-ment for bipolar disorder in guidelines (Ludwig et al. 2024; Malhi et al. 2017; Gitlin and Bauer 2024), as well as the recognition of a potential neuroprotective effect (Puglisi-Allegra et al. 2021; Rybakowski et al. 2018).”
Impact of Heavy Metals as Trace Elements on the Ecosystem and Health
Teschke, R., Chien, N. X., & Xuan, T. D. (2025) · Recent Progress in Nutrition · doi:10.21926/rpn.2504023 · Cited by 14
An Overview of the Effects of Lithium on Alzheimer’s Disease: A Historical Perspective
Radanovic, M., Singulani, M. P., de Paula, V. D. J. R., Talib, L. L., & Forlenza, O. V. (2025) · Pharmaceuticals · doi:10.3390/ph18040532 · Cited by 9
“Furthermore, it is important to determine whether there is conclusive evidence of such effects, considering the psychiatric status of lithium-treated patients and whether the battery of memory and cognitive tests used was the most appropriate for each case [34–36].”
InfluentialDemarquoy, J. (2025) · Acta Microbiologica Hellenica · doi:10.3390/amh70020018 · Cited by 7
“as a mood stabilizer and in battery technologies, exerts diverse effects on the gut microbiota, depending on its concentration [33].”
Metadata
- Authors
- Gitlin, M., & Bauer, M.
- Affiliations
- University of California, Los Angeles (US)
- University Hospital Carl Gustav Carus (DE)
- Corresponding author
- Gitlin, Michael
- Venue
- International Journal of Bipolar Disorders
- Published
- 2024-11-28
- Volume
- 12
- Issue
- 1
- Pages
- 40-40
- ISSN
- 2194-7511 (ISSN-L)
- PMC
- PMC11604892
- OpenAlex
- W4404794483
- Cited by
- 38
- References
- 126
- Citations by year
- 2026: 23 · 2025: 15
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- International Journal of Bipolar Disorders (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lithium, bipolar disorder, mania, major depressive disorder, mood disorders, lithium side effects, renal function, thyroid function, parathyroid function, suicide prevention, neuroprotection, mild cognitive impairment, dementia, stroke recovery, antiviral activity, cancer risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lithium: current state of the art and future directions. https://app.cochat.ai/papers/10.1186/s40345-024-00362-7
- The paper
- Gitlin, M., & Bauer, M. (2024). Lithium: current state of the art and future directions. International Journal of Bipolar Disorders. https://doi.org/10.1186/s40345-024-00362-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.